NCT00495456

Brief Summary

The burden of cardiovascular disease (CVD) is considerable, despite many advances in diagnosis, clinical management and drug therapy. The World Health Organization estimates 30% of global deaths are attributable to CVD and whilst mortality rates in developed countries are falling, it remains the largest single cause of death (WHO, 2007). Nineteen out of every 100 deaths in Australia are attributed to CVD, with an annual cost of $1.47 billion (AIHW, 2006). Assessing the risk of future cardiovascular events is traditionally based on a number of 'risk-factors' determined by observational clinical studies such as the Framingham cohort. Recent evidence however invalidates their use in both the highest and lowest risk groups and raises questions about applying such methods in changing risk-behaviour. A considerable number of new risk markers have surfaced in recent years (including various biomarkers, pulse wave velocity and measures of arterial function). Unfortunately their long-term predictive capacity is largely unknown, particularly when compared with existing risk factors. The aims of this study are to provide objective longitudinal data for a wide variety of risk markers both in current use and in development. Participants of current on-going clinical studies at will be approached to lengthen their observation period for the purposes of determining long-term clinical outcomes. Standard clinical observations and data obtained within the participant's enrolled studies will be collated into an electronic database. All existing and future studies must have individual approval from an appropriate ethics committee with signed consent. The baseline studies and follow-up assessments of this cohort will be correlated with cardiovascular events, hospitalizations and mortality. In addition, volunteers can be directed to appropriate clinical studies in CVD, thereby enhancing recruitment, encouraging good quality clinical studies and advancing knowledge of cardiovascular disease prevention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
665

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2007

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 3, 2007

Completed
29 days until next milestone

Study Start

First participant enrolled

August 1, 2007

Completed
14.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

April 13, 2022

Status Verified

April 1, 2022

Enrollment Period

14.3 years

First QC Date

July 2, 2007

Last Update Submit

April 11, 2022

Conditions

Keywords

cardiovascularrisklongitudinalprospective

Outcome Measures

Primary Outcomes (1)

  • To assess risk factors for cardiovascular disease.

    Annually

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants of current and future cardiovascular trials at the Centre of Clinical Research Excellence, Department of Epidemiology \& Preventive Medicine, Monash University, Melbourne.

You may qualify if:

  • Patients above 18 years of age

You may not qualify if:

  • Risk assessment would constitute harm to patient
  • Informed consent not obtainable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Box Hill Hospital

Box Hill, Victoria, Australia

Location

Caulfield General Medical Centre

Caulfield, Victoria, Australia

Location

The Northern Hospital

Epping, Victoria, Australia

Location

Alfred Hospital

Melbourne, Victoria, 3004, Australia

Location

Related Links

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Dipak Kotecha, MBChB MRCP

    Monash University

    PRINCIPAL INVESTIGATOR
  • John Varigos, BSc

    Monash University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

July 2, 2007

First Posted

July 3, 2007

Study Start

August 1, 2007

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

April 13, 2022

Record last verified: 2022-04

Locations